US1754117A - Method of reducing the poisonous effects of nicotine and the product thereof - Google Patents
Method of reducing the poisonous effects of nicotine and the product thereof Download PDFInfo
- Publication number
- US1754117A US1754117A US360256A US36025629A US1754117A US 1754117 A US1754117 A US 1754117A US 360256 A US360256 A US 360256A US 36025629 A US36025629 A US 36025629A US 1754117 A US1754117 A US 1754117A
- Authority
- US
- United States
- Prior art keywords
- nicotine
- tobacco
- toxicity
- reducing
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/22—Treatment of tobacco products or tobacco substitutes by application of electric or wave energy or particle radiation
Definitions
- This invention relates to the reduction of the physiologically poisonous or toxic efiects of nicotine, and with regard to certain more specific features to such reduction "without removal from a substance of the nicotine per se.
- Fig. 1 is a diagra a test
- T ig 2 is a diagrammatic view illustrating a method of treatment
- Fig, 3 is a view similar to Fig. 2, illustrating a modified form of treatment.
- Fig. A is a view similar tolFig. 2 illustrating another modification.
- tobacco will. be referred to as the substance in which the poisonous efi'ects of nicotine are to be reduced and/or neutralized, It is to be understood that other nicotine-bean ing substances, or even nicotine itself, may be similarly treated with the same or similar result 1n; matic view illustrating It is also to be understood that the term tobacco as used herein refers to cured or aged tobacco, such as is generally utilized in commerce for the manufacture of cigars, cigarettes, pipe tobacco and the like.
- the quantity of nicotine present in tobacco is not a criterion of the toxicity of the tobacco, inasmuch as the condition in which the nicotine exists is the determining criterion for determination of its physiological effects.
- two samples of tobacco may have equal amounts of nicotine but on the other hand be unequally toxic, because in one, the condition of the nicotine is different from the same amount in the other.
- the determination of the amount of ergosterol in a fat is not a measure of the amount of vitamin D in that fat, although vitamin D and ergosterol answer the same chemical tests.
- the characteristic action of nicotine may be noted by its efiect upon the frog, the animal evidencing a folding of the hind legs over the back. This action is suificiently characteristic to make it possible to distinguish nicotine from its related poisons, and is sensitive to the point where the presence of about mg. of nicotine may be demonstrated.
- a bent tube '5 passes through the stopper 3 and ends just below it.
- a thistle funnel 7. 5 passes through the second perforation and reaches nearly to the bottom of the jar.
- the jar is placed on a glass plate 9 and sealed reasonably air-tight by coating the contact between the jar and the plate with petrolatum.
- a frog 11 is introduced into the Bell jar and the jar is placed in its position on the plate.
- the thistle funnel is filled with tobacco 13, lighted, and the smoke is aspirated into the .jar.-
- tobacco for cigarettes, pipes, cigars, snufi and other purposes may be accuratelytested for toxicity of nicotine independently of the ordinary chemical tests for nicotine.
- Another method for the determination of by bubbling the smoke obtained from a weighted amount of tobacco through water, and injecting an aliquot part into any suitable animal prepared by the usual physiological 0 methods for the determination of blood pressure, nicotine being the only constituent of smoke that raises the blood pressure.
- the amount of rise is a measure of the amount of detrimental effect of the nicotine.
- Bubbling can be effected by placing a glass of water around the lower end of the funneltube 7 (see dotted lines Fig. 1).
- the tobacco of commerce retain all of its original constituents in order to be perfectly salable. That is to say, tobaccowhich has the nicotine content actually removed, such as by washing or the like, is not as salable as that which has the nicotine content left therein in a harmless form.
- tobacco which has the nicotine content actually removed, such as by washing or the like, is not as salable as that which has the nicotine content left therein in a harmless form.
- the original physical makeup of the tobacco (or other substance) is unchanged but the advantage is had that the nicotine is rendered substantially harmless and at least less toxic.
- the cut, sliced, minced or otherwise prepared tobacco is exposed in thin layers to infrared rays, for example in the following fashion (Fig.
- a layer 13 of tobacco 2.5 the tobacco undergoes a general absorption of infra-red radiation which, in the presence of air, results in a change in the nicotine.
- the change is apparently one of oxidation, the nicotine becomin acid. It is to be understood that t is explanation of the phenomenon may not be the ultimate one for the radiation changes may impart other andas yet unknown characteristics which have thus far eluded detection.
- the treatment can be accomplished also in a similar fashion by passing t e tobacco under mercury vapor lamps 1n quartz 23, by
- the mercury vapor lamp in quartz replaces theinfra-red generator (see i c ange may also be. effected in the case of nicotine by means of intensified visible light, such as that obtained from an incandescent lamp 25 (Fig. 4) with a range of wavelengths of 'fromx302 a to A1400 p..
- .By the term .intensified is meant herein light of intensity nicotinic greater than that to which tobacco or the substance being treated is normally exposed If freshly prepared nicotine is placed n a a pyrex test tube and this be suspended 1n 5 the path of the light furnished by a searchlight operating with a 1000 Watt Mazda lamp, the color of the nicotine changes quickly, and coincident with the color change the tom'city is lessened. W ln all the examples above enumerated it is understood that the increase or the decrease of light intensity will involve corresponding changes in the time of exposure, the distance from the light source to the nicotine or the 115 nicotine-containing material, and other obvious photochemical factors.
- the method cit treating cured tobacco containing toxic nicotine which comprises artificially irradiating said tobacco, to reduce the toxicity oil the nicotine content of said tobacco, and substantiall maintaining said as nicotine content unaltere 2.
- the method of treating cured tobacco containing toxic nicotine which comprises subjecting the same to artificial ultra-violet irradiation tor a sufficient length at time to detoxify the nicotine content out said tobacco, and substantially maintaining said nicotine content unaltered 3,
- the product comprising irradiated cured tobacco, the nicotine therein being detoxified but without substantial alteration otherwise in its essential characteristica In testimony whereofi'l have signed my name to this specification this Nth-day of April, 1929. m AUGUST P filll lll.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
Aprifl & 193%.. A. J. PAcnNn 1,7549117 METHOD OF REDUCING THE POISONOUS EFFECTS OF NICOTINE AND THE' PRODUCT THEREOF Filed May 5, 1929 Patented pr. 8, 1930 UNITED STATES PATENT OFFICE AUGUST J. PACINI, OF CHICAGO, ILLINOIS, ASSIGNOR T CHARLES M. RICHTER, OF
CHICAGO,
ILLINOIS METHOD OF REDUCING TIHE POISONOUS EFFECTS OF NICOTIINE AND THE PRODUCT THEREUF Applicafion filed May A, 1929. terial No. 360,256.
This invention relates to the reduction of the physiologically poisonous or toxic efiects of nicotine, and with regard to certain more specific features to such reduction "without removal from a substance of the nicotine per se.
Among the several objects of the invention may be noted the provision of means for treating substances having a nicotine content such that the said nicotine content will be m rendered less toxic, the treatment being ac- 7 enjoyment or use of the substance, tobacco hit for example, is not interfered with. Other objects will be in part obvious and in part pointed out hereinafter.
The invention accordingly comprises the elements and combinations of elements, steps and sequences of steps, features of synthesis and arrangements of parts which will be exemplified in the description hereinafter and the scope of the application of which will be indicated in the following claims.
In the accompanying drawings, in which is shown one of various possible embodiments of the invention,
Fig. 1 is a diagra a test; I
T ig 2 is a diagrammatic view illustrating a method of treatment;
Fig, 3 is a view similar to Fig. 2, illustrating a modified form of treatment; and,
Fig. A is a view similar tolFig. 2 illustrating another modification.
Similar reference characters indicate corresponding parts throughout the several views of the drawings,
Hereinafter, as an example and for the purpose of demonstrating the efiect of this invention, tobacco will. be referred to as the substance in which the poisonous efi'ects of nicotine are to be reduced and/or neutralized, It is to be understood that other nicotine-bean ing substances, or even nicotine itself, may be similarly treated with the same or similar result 1n; matic view illustrating It is also to be understood that the term tobacco as used herein refers to cured or aged tobacco, such as is generally utilized in commerce for the manufacture of cigars, cigarettes, pipe tobacco and the like.
Before describing the invention, the following should be noted: The quantity of nicotine present in tobacco, as determined by the usual methods of assay (non-biological) is not a criterion of the toxicity of the tobacco, inasmuch as the condition in which the nicotine exists is the determining criterion for determination of its physiological effects. Thus according to the ordinary tests, two samples of tobacco may have equal amounts of nicotine but on the other hand be unequally toxic, because in one, the condition of the nicotine is different from the same amount in the other. As illustrative of this fact in a different field, it may be noted that the determination of the amount of ergosterol in a fat is not a measure of the amount of vitamin D in that fat, although vitamin D and ergosterol answer the same chemical tests. The reason is, as in the case of the present invention, that the distinguishing criterion is biological. Thus an assay of tobacco before and after the treatment outlined herein appears to provide the same amount of nicotine by ordinary tests, yet biologically the effects of this nicotine are difierent.
As an example of What is referred to above, 1 have found that nicotine produces definite pharmacologic eflects when administered to different animals. The efl'ect is observed whether the nicotine be administered in its alkaloidal form, or Whether it be administered in its natural occurrence as tobacco.
The characteristic action of nicotine may be noted by its efiect upon the frog, the animal evidencing a folding of the hind legs over the back. This action is suificiently characteristic to make it possible to distinguish nicotine from its related poisons, and is sensitive to the point where the presence of about mg. of nicotine may be demonstrated.
In order to estimate with relatively accufit) racy the comparative toxicity of untreated tee set out herein, a Bell jar 1, (Fig. 1) tubulated, is fitted with a doubly perforated stopper 3.
A bent tube '5 passes through the stopper 3 and ends just below it. A thistle funnel 7. 5 passes through the second perforation and reaches nearly to the bottom of the jar. The jar is placed on a glass plate 9 and sealed reasonably air-tight by coating the contact between the jar and the plate with petrolatum. A frog 11 is introduced into the Bell jar and the jar is placed in its position on the plate. The thistle funnel is filled with tobacco 13, lighted, and the smoke is aspirated into the .jar.- Depending upon the amount of smoke consumed, and the time required for the symptoms of toxicity to appear, it is possible to estimate with relative accuracy the comparative toxicity of a treated and an untreated tobacco. By this method, tobacco for cigarettes, pipes, cigars, snufi and other purposes may be accuratelytested for toxicity of nicotine independently of the ordinary chemical tests for nicotine.
Another method for the determination of by bubbling the smoke obtained from a weighted amount of tobacco through water, and injecting an aliquot part into any suitable animal prepared by the usual physiological 0 methods for the determination of blood pressure, nicotine being the only constituent of smoke that raises the blood pressure. The amount of rise is a measure of the amount of detrimental effect of the nicotine. Bubbling can be effected by placing a glass of water around the lower end of the funneltube 7 (see dotted lines Fig. 1).
In regard to my invention .per se, I have found that nicotine ordinarily absorbs in the ultraviolet region at 280 m and in more diluted concentrations, at 270 my. I have discovered that the absorption ofnicotine in this region is not selective, but is general.
I have discovered further that the exposure of nicotine, or of tobacco leaf, cut or uncut, to ultraviolet radiation of wavelengths of from 4000 Angstrom units to the limit ofa mercury vapor lamp in quartz (approximately 1800 Angstrom units), or the exposure of nicotine to infrared radiation peaked especially in the regionv of 2.5 mar. results-in the toxicity of the nicotine being diminished. I have demonstrated, this repeatedly in the manner set out.
above, that is, by biological tests. Thus it will be seen thattobacco'wlien treated either by ultra-violet rays or infra-red rays loses much of its toxicity. This loss of toxicity is a fact as shown by the biological assays, al-
. though the ordinary physical and/or chemical assays, showthat tobacco before and after treatment appears .to have the same amount of nicotine perse. The conclusion is that the 1 condition or "biological characteristics or the hke of the nicotine have been changed after the loss in the toxic quality consists in passing treatment, although apparently the nicotine remains as a substance.
The above efl'ect is exceedingly desirable, because it is preferable that the tobacco of commerce retain all of its original constituents in order to be perfectly salable. That is to say, tobaccowhich has the nicotine content actually removed, such as by washing or the like, is not as salable as that which has the nicotine content left therein in a harmless form. By means of this invention the original physical makeup of the tobacco (or other substance) is unchanged but the advantage is had that the nicotine is rendered substantially harmless and at least less toxic. Referring now to the method of treatment, the cut, sliced, minced or otherwise prepared tobacco is exposed in thin layers to infrared rays, for example in the following fashion (Fig. 2): A layer 13 of tobacco 2.5 the tobacco undergoes a general absorption of infra-red radiation which, in the presence of air, results in a change in the nicotine. The change is apparently one of oxidation, the nicotine becomin acid. It is to be understood that t is explanation of the phenomenon may not be the ultimate one for the radiation changes may impart other andas yet unknown characteristics which have thus far eluded detection.
The fact is that the toxicity of the nicotine content is greatly lowered by this treatment.
The treatment can be accomplished also in a similar fashion by passing t e tobacco under mercury vapor lamps 1n quartz 23, by
which method, the mercury vapor lamp in quartz replaces theinfra-red generator (see i c ange may also be. effected in the case of nicotine by means of intensified visible light, such as that obtained from an incandescent lamp 25 (Fig. 4) with a range of wavelengths of 'fromx302 a to A1400 p..
These are radiations usually emitted by the general type of tungsten, incandescent lamp inclosed in lass. I have discovered that nicotine fres 1y repared from tobacco undergoes a color change when exposed to the radiations mentioned in the presence of air, and I have discovered further that this color change is attended by a marked reduction in the-toxicity of the nicotine. ".By the term .intensified is meant herein light of intensity nicotinic greater than that to which tobacco or the substance being treated is normally exposed If freshly prepared nicotine is placed n a a pyrex test tube and this be suspended 1n 5 the path of the light furnished by a searchlight operating with a 1000 Watt Mazda lamp, the color of the nicotine changes quickly, and coincident with the color change the tom'city is lessened. W ln all the examples above enumerated it is understood that the increase or the decrease of light intensity will involve corresponding changes in the time of exposure, the distance from the light source to the nicotine or the 115 nicotine-containing material, and other obvious photochemical factors.
The examples are merely illustrative andare not meant to limit and/or restrict the discovery to the factors of irradiation outlined.
'lheexamples indicate that applied mercury vapor radiation, applied visible light radiation and applied infra-red radiation are all capable of occasioning such changes in nicotine as to reduce its toxicity, without necessarily reducing its apparent physical and/or chemical content intobacco when determined by the ordinary present day methods. The change results in a biological diiierentiation.
In view of the above, it will be seen that so the several objects of theinvention are achieved and other advantageous results attained. a
As many changes could be made in carrying out the above constructions without departing from the-scope of the invention, it is intended that all matter contained in the above description shall be interpreted as illustrative and not in a limiting sense,
l claim:
to l The method cit treating cured tobacco containing toxic nicotine which comprises artificially irradiating said tobacco, to reduce the toxicity oil the nicotine content of said tobacco, and substantiall maintaining said as nicotine content unaltere 2. The method of treating cured tobacco containing toxic nicotine which comprises subjecting the same to artificial ultra-violet irradiation tor a suficient length at time to detoxify the nicotine content out said tobacco, and substantially maintaining said nicotine content unaltered 3, The product comprising irradiated cured tobacco, the nicotine therein being detoxified but without substantial alteration otherwise in its essential characteristica In testimony whereofi'l have signed my name to this specification this Nth-day of April, 1929. m AUGUST P filll lll.
tilt
mum; 1,754,117,
Certific ate of Cbrre'ctiori Grafited JAPriI S, 1930,.130 AUGUST PACIN I I t {e -hereby certified that error appears in the printed specificatieh of the ebovenumbered pfifent requiring correction as follows: Page 2, line 120, for A302 p. to. "A1400 14.. read A302 m to x1400 m and that the said Letters Patent shouldbe read Patent x I Si nedend see led this 14th da pf J1'1 1y, A.D. 1931.
i mj" J. MOORE, :Acting Commissioner of Patents.
wlth this cerreetion there in thatjhe same-may conform to the record of the case in the v
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US360256A US1754117A (en) | 1929-05-03 | 1929-05-03 | Method of reducing the poisonous effects of nicotine and the product thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US360256A US1754117A (en) | 1929-05-03 | 1929-05-03 | Method of reducing the poisonous effects of nicotine and the product thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US1754117A true US1754117A (en) | 1930-04-08 |
Family
ID=23417232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US360256A Expired - Lifetime US1754117A (en) | 1929-05-03 | 1929-05-03 | Method of reducing the poisonous effects of nicotine and the product thereof |
Country Status (1)
Country | Link |
---|---|
US (1) | US1754117A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2625938A (en) * | 1944-08-31 | 1953-01-20 | Int Cigar Mach Co | Filler feed for cigar bunch machines |
US3371670A (en) * | 1966-04-18 | 1968-03-05 | Carl R. Camenisch | Apparatus for curing tobacco |
US3378208A (en) * | 1965-10-19 | 1968-04-16 | Carl R. Camenisch | Method for accelerated curing of tobacco |
WO2016026911A3 (en) * | 2014-08-20 | 2016-04-21 | Philip Morris Products S.A. | Methods for forming aerosol-generating substrates having a reduced amount of tobacco specific nitrosamines |
-
1929
- 1929-05-03 US US360256A patent/US1754117A/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2625938A (en) * | 1944-08-31 | 1953-01-20 | Int Cigar Mach Co | Filler feed for cigar bunch machines |
US3378208A (en) * | 1965-10-19 | 1968-04-16 | Carl R. Camenisch | Method for accelerated curing of tobacco |
US3371670A (en) * | 1966-04-18 | 1968-03-05 | Carl R. Camenisch | Apparatus for curing tobacco |
WO2016026911A3 (en) * | 2014-08-20 | 2016-04-21 | Philip Morris Products S.A. | Methods for forming aerosol-generating substrates having a reduced amount of tobacco specific nitrosamines |
CN106714587A (en) * | 2014-08-20 | 2017-05-24 | 菲利普莫里斯生产公司 | Methods for forming aerosol-generating substrates having a reduced amount of tobacco specific nitrosamines |
RU2685845C2 (en) * | 2014-08-20 | 2019-04-23 | Филип Моррис Продактс С.А. | Methods for forming aerosol-generating substrates having a reduced amount of tobacco specific nitrosamines |
CN106714587B (en) * | 2014-08-20 | 2021-10-22 | 菲利普莫里斯生产公司 | Method for forming an aerosol-generating substrate having a reduced amount of tobacco-specific nitrosamines |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3966856B2 (en) | Activated carbon filter for reducing p-benzosemiquinone from tobacco mainstream smoke | |
Najjar et al. | Presence of a hitherto unrecognized nicotinic acid derivative in human urine. | |
US1754117A (en) | Method of reducing the poisonous effects of nicotine and the product thereof | |
DE1908756B2 (en) | FRAGRANCE COMPOSITION | |
US1920588A (en) | Method of treating tobacco | |
Pjon et al. | Phytochrome action in Oryza sativa L. II. The spectrophotometric versus the physiological status of phytochrome in coleoptiles | |
Pyfrom et al. | Catalase and Chlorophyll Depression by 3-Amino-1, 2, 4-Triazole. | |
NL8201585A (en) | Cigar coated with aroma-contg. microcapsules - gives smoke less unpleasant to non smokers without affecting cigar flavour | |
Kuperman et al. | Action of procaine on calcium efflux from frog nerve and muscle | |
Chalmers | The elimination of 3: 4-benzpyrene and other polycyclic hydrocarbons from the mouse | |
Kuratsune et al. | Decomposition of polycyclic aromatic hydrocarbons under laboratory illuminations | |
Giese | Some properties of a photodynamic pigment from Blepharisma | |
Mortimer et al. | The in vitro toxicity of the sporidesmins and related compounds to tissue-culture cells | |
US3631865A (en) | Smoking composition of reduced toxicity and method of making same | |
Yamaguchi et al. | Effect of color and intensity of fluorescent lights and application of chemicals and waxes on chlorophyll development of White Rose potatoes | |
Renwick et al. | Effects of sulfur dioxide on volatile terpene emission from balsam fir | |
Bando et al. | Changes in blue fluorescence intensity and coloration of human lens protein with normal lens aging and nuclear cataract | |
Griffith et al. | Determining chlorophyll, carotene, and xanthophyll in plants | |
NEMOTO et al. | Immunohistochemical demonstration of serotonin (5HT)-containing cells in the human and rat intestines | |
GIESE et al. | Studies on the red and blue forms of the pigment of Blepharisma | |
US3589374A (en) | Method of and container for treating tobacco to reduce alkaloid and tar content thereof | |
US2164030A (en) | Process for curing plant foliage | |
Hiatt et al. | Photodynamic inactivation of the vacuolating virus, SV40 | |
Valentine et al. | Detection of marijuana use in human saliva using a fluorometric assay based on cannabinol decomposition | |
Adamović | Aromatic amines as spray reagents in the thin-layer chromatography of chlorinated organic pesticides |